Skip to main content
. 2021 Jul 3;39(9):1085–1098. doi: 10.1007/s40273-021-01058-x
This study provides the first value set for the EORTC QLU-C10D for Spain. This preference-based measure is derived from the widely used cancer-specific quality-of-life questionnaire, EORTC QLQ-C30.
Cost-utility analysis (CUA) is an important component of reimbursement decisions in many countries, including Spain. The availability of the EORTC QLU-C10D value set supports CUA for cancer interventions in Spain and enables cross-country comparisons.